S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

Home
Investing
Stocks
USA
AMEX
Avanir Pharmaceuticl (AVN.R)
Avanir Pharmaceuticl (AVN.R) News

AVN.R

Avanir (AVN.R)

Avanir Pharmaceuticl

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:AMEX:AVN.R

1

Date	Time	Source	Headline	Symbol	Company
04/11/2006	7:00AM	Business Wire	AVANIR Stock to Commence Trading on the NASDAQ National Market System	AMEX:AVN.R	Avanir Pharmaceuticl
04/04/2006	7:00AM	Business Wire	AVANIR's Neurodex NDA Accepted with Priority Review for Involuntary Emotional Expression Disorder	AMEX:AVN.R	Avanir Pharmaceuticl
04/03/2006	3:15PM	Business Wire	AVANIR to Change Listing to the NASDAQ National Market System; Trading will Commence on April 11, Under the Ticker Symbol AVNR	AMEX:AVN.R	Avanir Pharmaceuticl
03/29/2006	3:15PM	Business Wire	AVANIR Pharmaceuticals Invites Investors to Listen to the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals C	AMEX:AVN.R	Avanir Pharmaceuticl
03/01/2006	3:15PM	Business Wire	AVANIR Pharmaceuticals Hires Matthew R. Ruth as Vice President of Sales	AMEX:AVN.R	Avanir Pharmaceuticl
02/09/2006	3:05PM	Business Wire	AVANIR Pharmaceuticals Reports First Quarter of Fiscal Year 2006 Results	AMEX:AVN.R	Avanir Pharmaceuticl
02/06/2006	3:15PM	Business Wire	AVANIR Receives Approximately $4.2 Million from Exercise of Warrants	AMEX:AVN.R	Avanir Pharmaceuticl
02/06/2006	11:15AM	Business Wire	AVANIR Pharmaceuticals Holds Annual Meeting of Shareholders	AMEX:AVN.R	Avanir Pharmaceuticl
01/30/2006	5:00AM	Business Wire	AVANIR Submits Expanded Neurodex New Drug Application for the Treatment of Involuntary Emotional Expression Disorder	AMEX:AVN.R	Avanir Pharmaceuticl
01/18/2006	10:25AM	Business Wire	CORRECTING and REPLACING AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on Thursday, February 9,	AMEX:AVN.R	Avanir Pharmaceuticl
01/18/2006	7:30AM	Business Wire	AVANIR Pharmaceuticals Invites Investors to Its First Quarter Conference Call on February 9, 2006	AMEX:AVN.R	Avanir Pharmaceuticl

Showing the most relevant articles for your search:AMEX:AVN.R

1

Ishares Ftse Ital Midsma...

Gracechurch Card Program...

NextPoint Financial

ATAI Life Sciences NV

Strategic High 80 Divide...

Invesco Income Growth

Aurania Resources

Lepanto Cons Mng (CE)

Pepper Sparkz Trust No 4

Global Star Acquisition

Viper Networks (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions